Cefadroxil + Clavulanate Potassium Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness exports Cefadroxil + Clavulanate Potassium Tablets for treatment of bacterial infections requiring broader antibacterial coverage against resistant organisms. The formulation is widely prescribed in respiratory tract infections, urinary infections, skin infections, and ENT bacterial conditions.

Cefadroxil interferes with bacterial cell wall synthesis, while Clavulanate Potassium improves antibacterial activity by neutralizing resistance-causing bacterial enzymes. As a recognized Beta Lactamase Inhibitor Antibiotic Exporter, Genliva Wellness develops oral cephalosporin formulations with effective bacterial control and stable tablet quality.

Operating as a Cefadroxil Clavulanate Tablets Manufacturer in India, Genliva Wellness LLP supplies advanced antibacterial formulations to pharmaceutical distributors and international healthcare supply chains.

Cefadroxil + Clavulanate Potassium Tablets are formulated for resistant bacterial infection treatment.

Cephalosporin and clavulanate tablet combination
Effective against resistant bacterial strains
Helps manage respiratory and urinary infections
Stable oral tablet dosage form
Manufactured using premium pharmaceutical ingredients

This formulation is commonly used for resistant bacterial infection treatment and antibiotic therapies.

Treatment of respiratory tract infections
Management of urinary and ENT infections
Used in skin infection antibacterial therapies
Helps control resistant bacterial growth
Improves recovery from infectious conditions

Cefadroxil + Clavulanate Potassium Tablets deliver extended antibacterial coverage for resistant infections.

Effective against beta-lactamase resistant bacteria
Useful in respiratory and urinary infection treatment
Provides broader antibacterial effectiveness
Helps manage recurrent bacterial infections
Delivers dependable cephalosporin therapeutic action